Free Trial
OTCMKTS:VYCO

Vycor Medical (VYCO) Stock Price, News & Analysis

$0.07 0.00 (-0.14%)
As of 12:33 PM Eastern

About Vycor Medical Stock (OTCMKTS:VYCO)

Key Stats

Today's Range
$0.07
$0.07
50-Day Range
$0.07
$0.07
52-Week Range
$0.03
$0.13
Volume
10,768 shs
Average Volume
8,517 shs
Market Capitalization
$2.25 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Vycor Medical, Inc. designs, develops, and markets neurological medical devices and therapies in the United States and Europe. It operates through two segments: Vycor Medical and NovaVision. The Vycor Medical segment provides devices for neurosurgery comprising ViewSite Brain Access System, a retraction and access system for brain and spine surgeries. The NovaVision segment offers non-invasive computer-based rehabilitation targeted at people who have impaired vision as a result of stroke or other brain injury. It has a license agreement which grants for the license to provide NovaVision's products and therapies to patients and professionals in Germany, Austria and Switzerland. It primarily serves hospitals and medical professionals. Vycor Medical, Inc. was founded in 2005 and is headquartered in Boca Raton, Florida. Vycor Medical, Inc. is a subsidiary of Fountainhead Capital Management Limited.

Remove Ads
Receive VYCO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Vycor Medical and its competitors with MarketBeat's FREE daily newsletter.

VYCO Stock News Headlines

Vycor Medical, Inc. (VYCO)
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 different coins that have returned over 100%... But today, Chris is now making the biggest crypto call of his ENTIRE career…
Medical Review Board
Vycor Medical Inc
Vycor Medical Inc (VYCO)
See More Headlines

VYCO Stock Analysis - Frequently Asked Questions

Vycor Medical's stock was trading at $0.0699 on January 1st, 2025. Since then, VYCO stock has decreased by 1.4% and is now trading at $0.0689.
View the best growth stocks for 2025 here
.

Vycor Medical, Inc. (OTCMKTS:VYCO) posted its earnings results on Monday, August, 17th. The medical device company reported ($0.01) EPS for the quarter. The medical device company had revenue of $0.24 million for the quarter.

Shares of VYCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Vycor Medical investors own include Fly Leasing (FLY), Idera Pharmaceuticals (IDRA), ACADIA Pharmaceuticals (ACAD), Bellicum Pharmaceuticals (BLCM), Canopy Growth (CGC), CorMedix (CRMD) and Drone Aviation (DRNE).

Company Calendar

Last Earnings
8/17/2020
Today
3/13/2025
Next Earnings (Estimated)
4/14/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & medical instruments
Sub-Industry
Medical Equipment
Current Symbol
OTCMKTS:VYCO
Previous Symbol
OTCMKTS:VYCO
Employees
6
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-70,000.00
Pretax Margin
-13.19%

Debt

Sales & Book Value

Annual Sales
$1.46 million
Price / Cash Flow
N/A
Book Value
($0.10) per share
Price / Book
-0.69

Miscellaneous

Free Float
30,318,000
Market Cap
$2.25 million
Optionable
Not Optionable
Beta
0.66

Social Links

Unlock the Potential in Options Trading Cover

Options trading isn’t just for the Wall Street elite; it’s an accessible strategy for anyone armed with the proper knowledge. Think of options as a strategic toolkit, with each tool designed for a specific financial task. Get this report to learn how options trading can help you use the market’s volatility to your advantage.

Get This Free Report

This page (OTCMKTS:VYCO) was last updated on 3/13/2025 by MarketBeat.com Staff
From Our Partners